You can buy or sell Novavax and other stocks, options, ETFs, and crypto commission-free!
Novavax, Inc. Common Stock, also called Novavax, is a late-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. Read More It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. Its vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
52 Week High
52 Week Low
-$0.98 per share
-$0.74 per share